We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · December 28, 2022

Serum Sex Hormone–Binding Globulin Is a Mediator of the Association Between Intrahepatic Lipid Content and Type 2 Diabetes



Additional Info

Disclosure statements are available on the authors' profiles:

Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
Diabetologia 2023 Jan 01;66(1)213-222, PIHG Simons, O Valkenburg, MPH van de Waarenburg, MMJ van Greevenbroek, ME Kooi, JFA Jansen, CG Schalkwijk, CDA Stehouwer, MCGJ Brouwers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading